Newsletters
- Bay Area Newsletter
- Greater Los Angeles Newsletter
- Group Purchasing Newsletter
- Public Policy Newsletter
- Regulatory & Reimbursement Newsletter
- San Diego Newsletter
Regulatory & Reimbursement Newsletter
Regulatory and Reimbursement Newsletter | October 2025
October 6th, 2025
The FDA released its contingency plan and published a trio of cell and gene therapy-related draft guidance documents, finalized a guidance on tools for remotely evaluating drug manufacturing facilities, and more.
Regulatory and Reimbursement Newsletter | September 2025
September 8th, 2025
Biocom California submitted comments on the reauthorization of the Medical Device User Fee Amendments (MDUFA), FDA released its annual pharmaceutical quality report, and more.